TREATMENT OF UPPER EXTREMITY DEEP VEIN THROMBOSIS (DVT)

上肢深静脉血栓 (DVT) 的治疗

• 批准号: 7378103
• 负责人: SUMAN W RATHBUN
• 金额: $ 1.48万
• 依托单位: UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-03-01 至 2007-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7378103
• 关键词: TREATMENT; UPPER; EXTREMITY; DEEP; VEIN

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. OBJECTIVE: To document the long-term outcome (prognosis) of patients diagnosed with upper extremity deep-vein thrombosis (DVT) who are treated with Fragmin (dalteparin sodium injection) followed by Warfarin for 3 months. Specific Aims 1. To evaluate the incidence of recurrent venous thromboembolism in patients diagnosed with upper extremity DVT who are treated with Fragmin followed by Warfarin for 3 months. 2. To evaluate the incidence of major bleeding in patients diagnosed with upper extremity DVT who are treated with Fragmin followed by Warfarin for 3 months. 3. To evaluate the incidence of post-phlebitic syndrome at one year in patients with upper extremity DVT. 4. To gather descriptive/demographic data on patients with upper extremity DVT. 5. To perform a pharmacoeconomic assessment of treatment of upper extremity DVT using low molecular weight heparin.

这个子项目是利用由NIH/NCRR资助的中心拨款提供的资源的许多研究子项目之一。子项目和调查员(PI)可能从另一个NIH来源获得了主要资金，因此可能会出现在其他CRISE条目中。列出的机构是针对中心的，而不一定是针对调查员的机构。目的：探讨法格明联合华法令治疗上肢深静脉血栓形成(DVT)3个月的远期疗效。具体目的1.评价法格明联合华法林治疗上肢深静脉血栓形成患者3个月后静脉血栓复发的发生率。2.观察法格明联合华法令治疗上肢深静脉血栓患者3个月后大出血的发生率。3.评估上肢深静脉血栓患者一年内静脉后综合征的发生率。4.收集上肢深静脉血栓患者的描述性/人口学数据。5.对低分子肝素治疗上肢深静脉血栓进行药物经济学评价。